Efficacy of Antihypertensive Medication in Orthotopic Heart Transplant Recipients and its Effect on Renal Function
- 1 July 1992
- journal article
- Published by SAGE Publications in Angiology
- Vol. 43 (7) , 585-589
- https://doi.org/10.1177/000331979204300707
Abstract
The authors looked at 77 patients following orthotopic heart transplant who received a triple immunosuppressive regimen including cyclosporine to see the effect of various antihypertensive medications on mean arterial blood pressure and renal function. There were 62 men and 15 women retrospectively classified into three groups according to the antihypertensive medications they received. Group 1 included 26 patients followed up for 10.7 ± 2.7 months who received hydralazine therapy. Group 2 included 32 patients followed up for 9.0 ± 3.4 months who received angiotensin-converting enzyme inhibition therapy. Group 3 included 19 patients followed up for 10.1 ± 3.3 months who received beta- adrenergic blocking agents. Mean arterial pressure (MAP), serum blood urea nitrogen (BUN), and serum creatinine (CR) were determined for each group at the start and end of the follow-up period. The MAP at the start of the study was 107 ± 14 in group 1,110 ± 13 in group 2, and 100 ± 11 in group 3. It was not statistically significantly different in any of the groups.Keywords
This publication has 5 references indexed in Scilit:
- Cardiac transplant hypertensionThe American Journal of Cardiology, 1990
- Safety Profiles of the Angiotensin-Converting Enzyme InhibitorsDrugs, 1988
- Early and Late Forms of Cyclosporine Nephrotoxicity: Studies in Cardiac Transplant RecipientsAmerican Journal of Kidney Diseases, 1987
- Cyclosporine NephrotoxicityAnnals of Internal Medicine, 1983
- Cardiac Transplantation with Cyclosporin A and PrednisoneAnnals of Surgery, 1982